Quantum Biopharma (NASDAQ:QNTM) Issues Quarterly Earnings Results

Quantum Biopharma (NASDAQ:QNTM) posted its quarterly earnings data on Friday. The company reported ($2.89) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($2.09), Zacks reports.

Quantum Biopharma Stock Performance

Quantum Biopharma stock opened at $8.56 on Friday. Quantum Biopharma has a 1 year low of $2.70 and a 1 year high of $18.00. The firm has a 50 day moving average price of $6.20 and a 200 day moving average price of $5.05. The company has a market cap of $16.43 million, a price-to-earnings ratio of -0.56 and a beta of 0.37.

Quantum Biopharma Company Profile

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.